NDC 0024-5869-01 - TOUJEO
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0024-5869
- Requested NDC
- 0024-5869-01
- Package NDCs from labels
- 0024-5869-01, 0024-5869-03, 0024-5869-00
- Manufacturer
- Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOUJEO - Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation | Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| TOUJEO - A-S Medication Solutions | A-S Medication Solutions | 2023-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0024-5869-00 | TOUJEO | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 25 | |
| 0024-5869-00 | TOUJEO | 1.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 1.5 | 25 | |
| 0024-5869-01 | TOUJEO | 1.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 1.5 | 25 | |
| 0024-5869-03 | TOUJEO | 3 in 1 CARTON | INJECTION, SOLUTION | 3 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0024-5869 | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION TOUJEO MAX (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 24 | Current NDC, Legacy NDC, 4 package rows | 20250319_c9561d96-124d-48ca-982f-0aa1575bff36.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0024-5869-00 | ML - Milliliter | 0024-5869 | 37c667e4-ce5b-4f9f-8bf7-b7ff3b00070c | 1 | 2021-06-02 |
| 0024-5869-01 | ML - Milliliter | 0024-5869 | 43f5217b-8e34-49dd-b0be-c1b2d5a05a97 | 1 | 2017-11-06 |
| 0024-5869-03 | ML - Milliliter | 0024-5869 | ce96366d-7fde-4e4b-92ff-e6cdc6ac9ef7 | 1 | 2015-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| insulin glargine | ACTIVE INGREDIENT | 2ZM8CX04RZ | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| insulin glargine | ACTIVE MOIETY | 2ZM8CX04RZ | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| metacresol | INACTIVE INGREDIENT | GGO4Y809LO | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 | |
| zinc | INACTIVE INGREDIENT | J41CSQ7QDS | TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | a73404d5-7843-4a9a-ad43-613df22f52e7 | 2026-01-14 | Warnings | PDC6A3C0OX |
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | eff2f43e-5626-48eb-a70e-334492977204 | 2026-01-14 | Warnings | PDC6A3C0OX |
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | c92ca67b-bea2-4be0-95ab-15f9b55568c1 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Rite-Aid Glycerin Laxative | GLYCERIN SUPPOSITORY | RITE AID CORPORATION | 0fb8f488-3386-29b9-e063-6294a90a014c | 2026-01-14 | Warnings | PDC6A3C0OX |
| Rite-Aid Childrens Glycerin Laxative | GLYCERIN SUPPOSITORY | RITE AID CORPORATION | 0fbe4dfd-1d5d-fc31-e063-6394a90ab317 | 2026-01-14 | Warnings | PDC6A3C0OX |
| GNP Hemorrhoidal Maximum Strength | HEMORRHOIDAL | Amerisourcebergen Drug Corporation | 24103355-cd72-55b0-e063-6394a90a90ec | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, ProctalgiaSuppositories | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1d40d16a-ee52-463a-e063-6394a90a6077 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Anal Care GLO pack | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 26612dae-21a0-6f12-e063-6394a90afe93 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, Proctalgia Relief Wash | CARBON, PANTHENOL, SODIUM HYALURONATE | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1e20de39-45b0-54ec-e063-6294a90a04ed | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, Proctalgia Ointments | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL, GLYCERIN | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1efe43d5-a29b-5cb2-e063-6394a90aca66 | 2026-01-14 | Warnings | PDC6A3C0OX |
| ST MORIZ SUNCARE BODY SUNSCREEN SPF30 | SUNCARE BODY SUNSCREEN SPF30 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 48026f09-6d15-8fa6-e063-6294a90a17cb | 2026-01-09 | Warnings | PDC6A3C0OX |
| Prostate Drops 2052 | PROSTATE DROPS | Professional Complementary Health Formulas | 8f6985b4-a450-45e1-9393-3d6f2f248e18 | 2026-01-08 | Warnings | J41CSQ7QDS |
| Male Balance Liquescence 3034 | MALE BALANCE LIQUESCENCE | Professional Complementary Health Formulas | 8e0eb969-d946-469e-b2af-375eb5ad931e | 2026-01-08 | Warnings | J41CSQ7QDS |
| Oxy Bee Pollen Liquescence 3012 | OXY BEE POLLEN LIQUESCENCE | Professional Complementary Health Formulas | 2d6cade7-7e1b-4859-b538-9d0ab70cccb8 | 2026-01-08 | Warnings | J41CSQ7QDS |
| Pancreas DB Liquescence 3037 | PANCREAS DB LIQUESCENCE | Professional Complementary Health Formulas | 30bc86e9-538b-449a-af48-99aafc405924 | 2026-01-08 | Warnings | J41CSQ7QDS |
| Brain Enhancement Liquescence 3006 | BRAIN ENHANCEMENT LIQUESCENCE | Professional Complementary Health Formulas | 33bb2104-c16a-49e4-b292-69e10c1f16c0 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Pain Formula II Drops 2090 | PAIN FORMULA II DROPS | Professional Complementary Health Formulas | b395d69b-8e6b-4ffc-9d6e-2ecd503aa177 | 2026-01-08 | Warnings | J41CSQ7QDS |
| Adrenal Liquescence 3001 | ADRENAL LIQUESCENCE | Professional Complementary Health Formulas | 0388d3c7-4b3b-4e74-8c1b-9a2af2a4377d | 2026-01-08 | Warnings | J41CSQ7QDS |
| Hysteria Drops 2119 | HYSTERIA DROPS | Professional Complementary Health Formulas | 7fe11cce-22f4-47e8-8006-ff5b2b2b2371 | 2026-01-08 | Warnings | J41CSQ7QDS |
| Memory Drops 2043 | MEMORY DROPS | Professional Complementary Health Formulas | a9b8897b-e5a1-4db3-94dd-8012aded6ed7 | 2026-01-08 | Warnings | J41CSQ7QDS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.